Xenomorph
  • Solutions
  • Technology
  • Customers
  • Resources
  • News
  • About Us
  • Request a Demo
  • Search
  • Menu Menu
  • Twitter
  • LinkedIn

News

PRMIA on ETFs #4 and #5 – ETF regulation and risk management

Katherine Moriaty was a very interesting speaker at the ETF event, and she talked us through some of the regulatory issues in relation to ETFs, particularly in relation to non-transparent ETFs. Katherine provided some history on the regulation of the fund industry in the US, particularly in relation to the Investment Company Act of 1940 which was enacted to restore public confidence in the fund management industry following the troubled times of the late 1920's and through the 1930's.

The fundamental concern for the SEC (the regulatory body for this) is that the provider of the fund products cannot game investors, providing false or incorrect valuations to maximize profits. Based on the "'40 Act" as she termed it, the SEC has allowed exemptions to allow various index and fund products, such as for smart indices you need full disclosure of the rules involved, plus with active indices then constituents are published. However with active ETFs, retail investors are at a disadvantage to authorized participants (APs, the ETF providers) since there is no transparency around the constituents.

Obviously fund managers want to manage portfolios without disclosure (to maintain the "secrets" of their success, to keep trading costs low etc), but no solution has yet been found to allow this for ETFs that satisfies the SEC that the small guy is not at risk from this lack of transparency. Katherine said that participants were still still trying to come up with solutions to this problem and the SEC is still open to an exemption for anything that in their view, "works" (sounds like someone will make a lot of money when/if a solution is found). Solutions tried so far include using blind trusts and proxy or shadow portfolios. Someone from the audience asked about the relative merits of Active ETFs when compared to Active Mutual Funds – Katherine answered that the APs wanted an exchange traded product as a new distribution channel (and I guess us "Joe Soaps" want lower fees for active management…)

Vikas Kalra of MSCI had the uneviable position of giving the last presentation of the evening, and he said he would keep his talk short since he was aware he was standing between us and the cocktail reception to follow. Vikas described the problem that many risk managers faced, which was that doing risk management for a portfolio containing ETFs was fine when the ETF was of a "look through" type (i.e. constituents available), but when the ETF is opaque (no/little/uncertain constituent data) then the choices were usually 1) remove the ETF from the risk calculation or 2) substitute some proxy instrument.

Vikas said the Barra part of MSCI had come up with the solution to analyse ETF "styles". From what I could tell, this looked like some sophisticated form of 2) above, where Barra had done the analysis to enable an opaque ETF to be replaced by some more transparent proxy which allowed constituents to be analysed within the risk process and correlations etc recognised. Vikas said that 400 ETFs and ETNs were now covered in their product offering.

Conclusion – Overall a very interesting event that improved my knowledge of ETFs and had some great speakers.

Share this entry
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://www.xenomorph.com/wp-content/uploads/2019/07/logo-xeno.png 0 0 Brian Sentance https://www.xenomorph.com/wp-content/uploads/2019/07/logo-xeno.png Brian Sentance2013-04-23 23:26:042019-07-03 10:23:14PRMIA on ETFs #4 and #5 – ETF regulation and risk management

Categories

  • Blog Post
  • Events
  • Press Release

Archives

About Xenomorph

Xenomorph provides trusted data management solutions to many of the world’s leading financial institutions.

With more than two decades’ experience managing large volumes of complex data and analytics we can quickly configure a solution for your requirements.

Xenomorph London

4th Floor
10 Lloyd’s Avenue
London EC3N 3AJ
UK

+44 (0)20 7614 8600

info@xenomorph.com

map

Xenomorph New York

45 Rockefeller Plaza, FL 20
New York
NY 10111
USA

+1-212-401-7894

info@xenomorph.com

map


Xenomorph Boston

53 State Street
Suite 500
Boston, MA 02109
USA

+1-617-465-2050

info@xenomorph.com

map

© Xenomorph Software Ltd 2022 - Privacy policy | Anti-Bribery Policy
Scroll to top
This website uses cookies to improve your experience. If you continue to use the site we will assume your consent. ACCEPTRead More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT